Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
Ophthalmology|December 18, 2016
Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional StudyTomas S Aleman, Grace Han, Leona W Serrano, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|December 22, 2023
Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5Randa T H Li, Alejandro J Roman, Alexander Sumaroka, et al.
Human Gene Therapy|July 9, 2009
Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 yearArtur V Cideciyan, William W Hauswirth, Tomas S Aleman, et al.
Plos Medicine|June 28, 2007
Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutationGeoffrey K Aguirre, András M Komáromy, Artur V Cideciyan, et al.
Human Gene Therapy|July 8, 2010
Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in IsraelEyal Banin, Dikla Bandah-Rozenfeld, Alexey Obolensky, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2005
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy successSamuel G Jacobson, Tomas S Aleman, Artur V Cideciyan, et al.
Neurobiology of Aging|March 1, 2023
Retinal photoreceptor layer thickness has disease specificity and distinguishes predicted FTLD-Tau from biomarker-determined Alzheimer's diseaseBenjamin J Kim, Murray Grossman, Tomas S Aleman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
In utero gene therapy rescues vision in a murine model of congenital blindnessNadine S Dejneka, Enrico M Surace, Tomas S Aleman, et al.
Scientific Reports|July 2, 2025
Choroidal evaluation of FTLD-Tau and biomarker-determined Alzheimer's diseaseBenjamin J Kim, Tomas S Aleman, Katheryn A Q Cousins, et al.
Pageof 20